The effect of heparin and fibrin on the enzymatic efficiencies of thrombolytics in vitro.
D004338:Drug Combinations / Q000378:metabolism; D004347:Drug Interactions; D005337:Fibrin / Q000494:pharmacology*; D005341:Fibrinolysin / Q000096:biosynthesis; D005343:Fibrinolytic Agents / Q000378:metabolism*; D006493:Heparin / Q000494:pharmacology*; D066298:In Vitro Techniques; D010446:Peptide Fragments / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D013300:Streptokinase / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D004338:Drug Combinations; D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C018998:lysyl-plasminogen; C049423:streptokinase-plasminogen complex; D005337:Fibrin; D010958:Plasminogen; D006493:Heparin; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator